JCR Pharmaceuticals has been granted a patent for software analyzing fertilized egg images to select embryos for transplantation based on pronucleus area differences. The method involves capturing images at intervals, measuring pronucleus areas, and selecting embryos meeting specific criteria for transplantation. GlobalData’s report on JCR Pharmaceuticals gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on JCR Pharmaceuticals, Nanoparticle drug conjugates was a key innovation area identified from patents. JCR Pharmaceuticals's grant share as of May 2024 was 43%. Grant share is based on the ratio of number of grants to total number of patents.
Software analyzing fertilized egg images for transplantation based on pronucleus area
A recently granted patent (Publication Number: US12002210B2) outlines a method for analyzing fertilized eggs to select the most viable candidates for transplantation into the uterine cavity. The method involves capturing images of the fertilized eggs at regular intervals and using a computer to detect and measure the male and female pronuclei. By calculating the areas of these pronuclei over time and analyzing the differences between them, the method aims to identify fertilized eggs with optimal characteristics for successful transplantation. The selection criteria include specific area differences between the pronuclei at different time points before pronuclear membrane breakdown, ensuring that only the most promising fertilized eggs are chosen for transplantation.
Furthermore, the patent describes a comprehensive analytical method for the transplantation of freeze-thawed blastocysts under hormone replacement therapy (HRT) with estrogen and progesterone. This method involves a series of steps, including ovarian stimulation, ovulation triggering, ova collection, fertilization, and embryo culturing. By capturing images of the fertilized eggs, measuring the pronuclei areas, and selecting the most suitable candidates based on calculated differences, the method aims to improve the success rate of blastocyst transplantation. The subsequent culturing of selected embryos to obtain blastocysts for transplantation into the uterine cavity allows for monitoring and assessing the birth status of the transplanted patients, providing valuable insights into the effectiveness of the overall procedure.
To know more about GlobalData’s detailed insights on JCR Pharmaceuticals, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
